Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01310699 · ClinicalTrials.gov registry record · NA

Study of Flat Polyp Detection Using New Narrow Band Imaging (NBI) Compared to White Light Colonoscopy - The FIND FLAT Colonoscopy Study

A NA study of Colorectal Cancer and Colorectal Neoplasms, sponsored by VA Palo Alto Health Care System.

Completed
Registry status
NA
Development phase
281
Enrollment target
3
Study locations

NCT01310699: Completed NA study of Colorectal Cancer and Colorectal Neoplasms, sponsored by VA Palo Alto Health Care System.

NCT01310699 is a NA study of Colorectal Cancer and Colorectal Neoplasms that has completed, run by VA Palo Alto Health Care System. The registered enrollment target is 281 participants, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (82% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01310699, a NA study of Colorectal Cancer and Colorectal Neoplasms, has completed, sponsored by VA Palo Alto Health Care System.

COMPLETED
Registry status
NA
Development phase
281 participants
Enrollment target
3
Study locations

Study Summary

We hypothesize that high definition narrow band imaging (NBI) colonoscopy compared to high definition white light colonoscopy will detect an increased number of nonpolypoid (flat and depressed) colorectal neoplasm.

Primary Outcome

Compare the nonpolypoid colorectal neoplasm detection characteristics of the new high definition narrow band imaging colonoscopy to conventional high definition white light mode colonoscopy.

Interventions

  • DEVICE Olympus Colonoscope CFHQ190AL

Study Locations (3)

California

  • Veterans Affairs Palo Alto - Palo Alto
  • Veterans Affairs San Francisco - San Francisco

Missouri

  • Veterans Affairs Kansas City - Kansas City

Trial Details

FieldValue
Enrollment Target 281 participants
Start Date 2013-01
Est. Completion 2016-08
Phase NA
VA Palo Alto Health Care System

34 total trials

What the finished NCT01310699 record still lists

NCT01310699 is an interventional study that assigns participants to a tested intervention. The registered 281 participants enrollment target is mid-sized for trials with a published cap, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (82% lower).

The record links to 3 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Olympus Colonoscope CFHQ190AL is the first listed.

NCT01310699 reports a single indexed study location in California, Missouri.

Frequently Asked Questions

What is clinical trial NCT01310699 about?

NCT01310699 is a clinical study titled "Study of Flat Polyp Detection Using New Narrow Band Imaging (NBI) Compared to White Light Colonoscopy - The FIND FLAT Colonoscopy Study". We hypothesize that high definition narrow band imaging (NBI) colonoscopy compared to high definition white light colonoscopy will detect an increased number of nonpolypoid (flat and depressed) colorectal neoplasm.

What is the current status of trial NCT01310699?

This trial is currently completed. It is a NA study. The enrollment target is 281 participants. The study started on 2013-01. Estimated completion is 2016-08.

What conditions does trial NCT01310699 study?

This clinical trial studies the following conditions: Colorectal Cancer, Colorectal Neoplasms, Colonic Polyps.

What interventions are being tested in trial NCT01310699?

The interventions under investigation include: Olympus Colonoscope CFHQ190AL (DEVICE).

Who is sponsoring clinical trial NCT01310699?

This trial is sponsored by VA Palo Alto Health Care System, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01310699 being conducted?

This trial has 3 study locations across California, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01310699's enrollment target sits among peer trials

281 121st of 381 higher than 261 of 381 other Colorectal Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04521231 · 281 participants · Phase 1

    A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL

  • NCT06190730 · 281 participants · NA

    REmote Symptom COllection to improVE postopeRative Care

  • NCT02860364 · 282 participants · NA

    Comparing Hypothermic Temperatures During Hemiarch Surgery

  • NCT04867395 · 282 participants · NA

    A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01310699, the US trial registry maintained by the National Library of Medicine. NCT01310699 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.